Search results
IREDA Shares Jump 6%, Crosses Rs 200 Mark On Q1 Business Update - News18
News18· 9 hours agoShares of the Indian Renewable Energy Development Agency (IREDA) rose 6 per cent in early deals...
Chandu Champion Day 18 BO: Kartik Aaryan starrer inches towards Rs 60 crore | Hindi Movie News -...
The Times of India· 9 hours agoChampion is heading for a respectable collection at the box office in the third week. The film...
Turkiye sacrifices its Uyghur affinity at the altar of ‘strategic partnership’ with China
Firstpost· 9 hours agoAfter the visit of Turkiye’s Foreign Minister Hakan Fidan to Xinjiang (Urumqi and Kashgar) in the...
How Julian Assange Shaped the 2016 Election
The Dispatch· 9 hours agoWikiLeaks was onto something. It was widely known at the time that Sanders’ voters were dissatisfied with the prospect of Hillary Clinton’s nomination....
Chemicals makers see silver lining after cloudy FY24 | Ahmedabad News - Times of India
The Times of India· 9 hours agoGujarat’s chemical sector faced a challenging year with declining orders and soaring raw material...
WATCH | 'Unemployed' Rahul Dravid At His Humorous Best As He Seeks 'Job Offers', Leaves All In...
One India· 10 hours agoDravid had previously stated he would not be extending his contract, making this his last assignment...
Sunak, Starmer both woo British Hindu voters - News Today | First with the news
News Today· 10 hours agoLabour Leader Keir Starmer, have hit the temple trail to woo British Hindu voters. While 44-year-old...
Wimbledon 2024: Carlos Alcaraz, Jannik Sinner set to renew rivalry amid Novak Djokovic threat; Will...
Hindustan Times· 10 hours agoAlcaraz, fresh from his maiden French Open win last month, will be facing stiff competition from...
'This is no redemption, I don't think on those lines' - Rahul Dravid | Cricket News - Times of India
The Times of India· 11 hours agoIndies 17 years ago left Rahul Dravid the captain shattered. The humiliation of crashing out at the...
10 clinical trials to watch in the second half of 2024
BioPharma Dive· 11 hours agoStudy results are expected for two closely watched obesity drugs, while key tests await for a...